Our results show that exposing cancer cells to CM from PCs protected them from the inhibitory effects of TKI drugs on Src and Akt phosphorylation and activation, compared to cells exposed to CM from cancer cells (Figure 4D; Figures S4D,E, Supporting Information). The gene discussed is SRC; the disease is cancer.